Tibra Equities Europe’s ICU Medical ICUI Stock Holding History

Tibra Equities Europe’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-17,239	Closed	-$5.06M	–	223
2018 Q2	$5.06M	Buy	+17,239	New	+$4.71M	0.76%	40

Other funds holding ICUI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Tibra Equities Europe's ICUI Position: Q3 2018 in Review

Tibra Equities Europe sold out of ICU Medical (ICUI) in Q3 2018, closing a stake of 17,239 shares — an estimated $5.06M sold.

Tibra Equities Europe first reported a position in ICUI in Q2 2018 and held it in 1 quarter. The position peaked at $5.06M in Q2 2018. 352 funds tracked by Wall St. Rank hold ICUI as of Q3 2018.

Tibra Equities Europe reported no remaining ICU Medical position as of Q3 2018 after selling out during the quarter.
Tibra Equities Europe sold 17,239 ICU Medical shares in Q3 2018, an estimated $5.06M.
Tibra Equities Europe first reported a position in ICU Medical in Q2 2018 and held it in 1 quarter.
Tibra Equities Europe's ICU Medical position peaked at $5.06M in Q2 2018.
352 funds tracked by Wall St. Rank held ICU Medical as of Q3 2018.

Based on Tibra Equities Europe's 13F filing for Q3 2018, filed 13 Nov 2018.